Advisors Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Buy
234,256
+11,951
+5% +$697K 0.24% 79
2025
Q4
$12M Buy
222,305
+10,375
+5% +$499K 0.2% 101
2025
Q3
$9.56M Buy
211,930
+5,729
+3% +$268K 0.16% 143
2025
Q2
$9.55M Sell
206,201
-22,752
-10% -$1.12M 0.17% 131
2025
Q1
$14M Sell
228,953
-24,575
-10% -$1.43M 0.26% 65
2024
Q4
$14.3M Buy
253,528
+41,089
+19% +$2.3M 0.26% 65
2024
Q3
$11M Buy
212,439
+49,137
+30% +$2.31M 0.2% 110
2024
Q2
$6.78M Buy
163,302
+29,164
+22% +$1.3M 0.13% 192
2024
Q1
$7.27M Buy
134,138
+42,509
+46% +$2.17M 0.14% 185
2023
Q4
$4.7M Buy
91,629
+20,989
+30% +$1.1M 0.1% 259
2023
Q3
$4.1M Sell
70,640
-10,653
-13% -$653K 0.09% 290
2023
Q2
$5.2M Sell
81,293
-10,198
-11% -$684K 0.11% 226
2023
Q1
$6.34M Sell
91,491
-2,615
-3% -$184K 0.13% 182
2022
Q4
$6.77M Sell
94,106
-7,871
-8% -$593K 0.14% 163
2022
Q3
$7.25M Buy
101,977
+2,035
+2% +$148K 0.15% 149
2022
Q2
$7.7M Buy
99,942
+2,548
+3% +$194K 0.15% 146
2022
Q1
$7.11M Buy
97,394
+7,428
+8% +$499K 0.11% 194
2021
Q4
$5.61M Buy
89,966
+8,755
+11% +$514K 0.08% 258
2021
Q3
$4.8M Buy
81,211
+13,365
+20% +$880K 0.07% 274
2021
Q2
$4.53M Buy
67,846
+12,580
+23% +$820K 0.07% 293
2021
Q1
$3.49M Buy
55,266
+9,794
+22% +$609K 0.05% 372
2020
Q4
$2.82M Buy
45,472
+5,480
+14% +$337K 0.05% 410
2020
Q3
$2.41M Buy
39,992
+8,244
+26% +$496K 0.04% 391
2020
Q2
$1.87M Buy
31,748
+2,098
+7% +$125K 0.04% 475
2020
Q1
$1.65M Sell
29,650
-70,788
-70% -$4.33M 0.04% 465
2019
Q4
$6.45M Buy
100,438
+8,118
+9% +$465K 0.11% 212
2019
Q3
$4.68M Sell
92,320
-466
-0.5% -$21.9K 0.09% 267
2019
Q2
$4.21M Sell
92,786
-3,111
-3% -$145K 0.08% 300
2019
Q1
$4.58M Buy
95,897
+33,762
+54% +$1.68M 0.08% 284
2018
Q4
$3.23M Buy
62,135
+36,445
+142% +$1.96M 0.07% 338
2018
Q3
$1.59M Sell
25,690
-648
-2% -$38.5K 0.03% 680
2018
Q2
$1.46M Sell
26,338
-5,301
-17% -$286K 0.02% 706
2018
Q1
$2.1M Sell
31,639
-5,197
-14% -$334K 0.04% 585
2017
Q4
$2.26M Sell
36,836
-84,729
-70% -$5.3M 0.04% 577
2017
Q3
$7.75M Sell
121,565
-5,567
-4% -$325K 0.13% 206
2017
Q2
$7.08M Sell
127,132
-6,959
-5% -$379K 0.12% 242
2017
Q1
$7.29M Sell
134,091
-4,606
-3% -$253K 0.12% 228
2016
Q4
$8.11M Buy
138,697
+49,745
+56% +$2.72M 0.13% 212
2016
Q3
$4.8M Buy
88,952
+63,866
+255% +$4.1M 0.08% 363
2016
Q2
$1.84M Buy
+25,086
New +$1.77M 0.03% 670
2016
Q1
Sell
-11,375
Closed -$782K 1807
2015
Q4
$782K Sell
11,375
-7,635
-40% -$505K 0.01% 988
2015
Q3
$1.13M Sell
19,010
-170,346
-90% -$10.8M 0.02% 853
2015
Q2
$12.6M Sell
189,356
-23,305
-11% -$1.54M 0.17% 159
2015
Q1
$13.7M Sell
212,661
-14,910
-7% -$933K 0.18% 149
2014
Q4
$13.4M Sell
227,571
-29,287
-11% -$1.65M 0.18% 153
2014
Q3
$13.1M Buy
256,858
+49,229
+24% +$2.46M 0.18% 159
2014
Q2
$10.1M Sell
207,629
-67,536
-25% -$3.33M 0.14% 199
2014
Q1
$14.3M Sell
275,165
-179,094
-39% -$9.53M 0.22% 119
2013
Q4
$24.1M Sell
454,259
-171,675
-27% -$8.75M 0.39% 58
2013
Q3
$29M Sell
625,934
-145,166
-19% -$6.37M 0.51% 40
2013
Q2
$34.5M Buy
+771,100
New +$33.5M 0.65% 19

Other funds holding BMY

Advisors Asset Management's BMY Position: Q1 2026 in Review

Advisors Asset Management increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q1 2026, buying an estimated $697K and bringing the position to 234,256 shares worth $14.2M. The position accounts for 0.24% of the portfolio, ranked #79.

Advisors Asset Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $34.5M in Q2 2013. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Advisors Asset Management held 234,256 shares of Bristol-Myers Squibb worth $14.2M as of Q1 2026.
  • Advisors Asset Management bought 11,951 Bristol-Myers Squibb shares in Q1 2026, an estimated $697K.
  • Bristol-Myers Squibb made up 0.24% of Advisors Asset Management's portfolio in Q1 2026, its #79 holding.
  • Advisors Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Advisors Asset Management's Bristol-Myers Squibb position peaked at $34.5M in Q2 2013.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.